A retired physician and his son allegedly operated a family-run pill mill that exploited vulnerable patients and fueled addiction, writing fraudulent prescriptions for highly addictive medications without medical examinations in what authorities describe as a brazen abuse of medical authority for profit.
Officials announced Thursday that a doctor and his son have been accused of operating a family-run pill mill in New York, in what authorities describe as a brazen abuse of medical authority to fuel the illegal distribution of prescription drugs. Over a roughly three-month period in 2022, the physician allegedly wrote fraudulent prescriptions for highly addictive medications without ever examining patients, while his son found buyers and collected payments as part of the scheme, according to the Drug Enforcement Administration.
Dr. Richard Taubman, a 71-year-old retired physician, and his 33-year-old son, Eric Taubman, surrendered Thursday to investigators with the Nassau County District Attorney's Office following an extensive, multiyear joint investigation. The father and son turned themselves in on Thursday and pleaded not guilty to multiple charges.
Betrayal of Medical Trust
DEA New York Enforcement Division Special Agent in Charge Farhana Islam said, "Their alleged scheme to unlawfully distribute controlled substance prescriptions, placing profits above public health, is not only reckless and dangerous, but unconscionable." She said, "Medical professionals are entrusted with protecting patients' lives, not destroying them by exploiting them to addiction and harm."
The statement underscores how the alleged scheme violated the fundamental duty of care that medical professionals owe to patients and society, turning a position of trust into a vehicle for harm.
According to the DEA, the father is a retired obstetrician-gynecologist from Great Neck who returned to practice at a non-surgical weight loss center in Islandia, in Suffolk County, in early 2022. Investigators allege that between April 5 and June 29, 2022, Taubman wrote dozens of prescriptions for controlled substances for multiple individuals without a legitimate medical purpose and outside the course of his practice.
How the Scheme Operated
Authorities say the pair distributed a wide range of drugs, including those commonly known as Percocet, Adderall and Xanax. He also submitted the prescriptions electronically from his home in Glen Head to pharmacies across Queens, officials further alleged.
Separately, the son allegedly provided the father with the personal information and drug requests of friends and acquaintances. The family operation allegedly turned medical credentials into a tool for drug trafficking, with the son serving as a middleman who connected buyers to his father's prescription-writing authority.
Numerous reports from pharmacist employees soon flooded the DEA, demonstrating how frontline pharmacy workers served as a critical check on prescription abuse. The agency said the father's prescription license was stripped roughly one month later, though the alleged damage had already been done.
Ripple Effects of Prescription Abuse
The investigation also revealed that some individuals allegedly circulated the drugs even further, selling them for profit, trading them for cash and other drugs, or simply using them. The cascading distribution pattern illustrates how prescription drug diversion creates networks of addiction and illegal commerce that extend far beyond the original fraudulent prescriptions.
They are specifically charged with 23 counts of illegally selling or trying to sell drug prescriptions, along with one count of illegally teaming up to carry out this scheme. If convicted, they face up to five and a half years in prison.
Why This Matters:
This case highlights the ongoing prescription drug crisis and the critical need for stronger oversight of medical professionals who abuse their authority. The alleged scheme exploited the trust society places in physicians, turning prescription-writing power into a profit-making enterprise that fueled addiction rather than treating illness. Frontline pharmacy workers who reported suspicious activity demonstrated the importance of regulatory safeguards and professional vigilance in protecting public health. The three-month window during which the alleged operation functioned shows how quickly prescription drug diversion can spread addiction and harm through communities. As the opioid and prescription drug epidemic continues to claim lives, cases like this underscore the need for robust licensing oversight, prescription monitoring programs, and accountability measures that prevent medical credentials from becoming tools for exploitation. The potential five-and-a-half-year maximum sentence raises questions about whether penalties adequately reflect the societal harm caused by medical professionals who betray their oath.